Niche Pill Delivery Leverage Canntab's patented hard pill cannabinoid and terpene formulations to target medical cannabis patients seeking precise, quantifiable dosing in a discreet oral dosage form, differentiating from standard oils and edibles.

Global Partnerships Capitalize on existing joint ventures and distribution networks in Australia and Asia, plus collaborations with Emblem Corp, to accelerate market entry, regulatory approvals, and localized product launches for new markets.

Regulatory Footprint Two products already hold Health Canada NPN numbers, indicating regulatory progress and potential faster access for add-on product lines and cross-border sales in regulated markets.

Strategic Leadership Recent leadership transitions and advisory hires signal a focus on scaling commercialization; align BD efforts with interim CEO and strategic consultants to secure fundraising, partnerships, and channel development.

Wellness Market Positioning Position as a premier medical oral dose administration solution within the growing wellness and therapeutic cannabis segment, pursuing partnerships with pharmacies, clinics, and Indigenous health programs to broaden patient access.